Spectrum of neuropsychiatric symptoms in chronic post-stroke aphasia

Table 1 Demographic and clinical characteristics of persons with aphasia

Patient	Sex/handedness	Age (yr)	Education (yr)	Stroke duration (mo)	Barthel index1	Lesion volume (cm3)	Aphasia type2	Antidepressants
1	F/R	50	12	80	80	113.33	Conduction	Sertraline
2	M/R	61	14	103	90	163.02	Broca	Citalopram
3	M/R	49	17	61	90	210.38	Broca	No
4	M/R	42	11	45	100	99.31	Anomic	Citalopram
5	M/R	63	8	11	85	23.16	Conduction	No
6	F/R	58	12	126	95	188.76	Anomic	No
7	M/R	60	12	45	60	44.96	Anomic	No
8	M/R	54	14	44	90	66.97	Anomic	No
9	M/R	51	13	7	80	225.69	Anomic	Amitriptyline
10	M/R	54	10	19	90	282.59	Wernicke	No
11	F/R	58	15	66	95	98.84	Broca	No
12	F/R	61	12	17	45	4.47	Anomic	Sertraline
13	M/R	32	18	10	100	34.01	Wernicke	Sertraline
14	M/R	49	8	13	80	17.45	Anomic	No
15	F/R	28	8	6	100	51.26	Anomic	No
16	F/R	65	17	13	100	26.10	Wernicke	No
17	M/R	64	17	120	100	157.58	Anomic	No
18	F/R	65	17	13	75	158.25	Broca	No
19	M/R	58	8	17	100	69.66	Wernicke	No
20	M/R	63	17	10	100	50.43	Wernicke	Fluoxetine
Median		58	12.5	18	90	84.25

¹Barthel Index measures participant´s independence in activities of daily living;

²Type of aphasia was obtained from fluency, comprehension, and repetition subtest of the Western Aphasia Battery-Revised.

F: Female; M: Male; R: Right-handed.